SC 13G: Aadi Bioscience, Inc.
Ticker: WHWK · Form: SC 13G · Filed: Aug 28, 2024 · CIK: 1422142
| Field | Detail |
|---|---|
| Company | Aadi Bioscience, INC. (WHWK) |
| Form Type | SC 13G |
| Filed Date | Aug 28, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Aadi Bioscience, Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Aadi Bioscience, INC. (ticker: WHWK) to the SEC on Aug 28, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti).
How long is this filing?
Aadi Bioscience, INC.'s SC 13G filing is 4 pages with approximately 1,051 words. Estimated reading time is 4 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,051 words · 4 min read · ~4 pages · Grade level 8.3 · Accepted 2024-08-28 16:42:02
Key Financial Figures
- $0.0001 — ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti
Filing Documents
- aadi13g.htm (SC 13G) — 73KB
- 0001373604-24-000079.txt ( ) — 75KB
(a)
Item 1(a). Name of Issuer: Aadi Biosciences, Inc.
(b)
Item 1(b). Address of Issuer's Principal Executive Offices: 17383 Sunset Blvd, Suite A250 Pacific Palisades, CA 90272
(a)
Item 2(a). Name of Person Filing: BML Investment Partners, L.P.
(b)
Item 2(b). Address of Principal Business Office or, if none, Residence: 65 E Cedar, Suite 2 Zionsville, IN 46077
(c)
Item 2(c). Citizenship: Delaware
(d)
Item 2(d). Title of Class of Securities: Common Stock
(e)
Item 2(e). CUSIP Number: 00032Q104 Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ . Item 4. (a) Amount beneficially owned: 1383817 (b) Percent of class: 5.6 (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 200000 (ii) Shared power to vote or to direct the vote: 1183817 (iii) Sole power to dispose or to direct the disposition of: 200000 (iv) Shared power to dispose or to direct the disposition of: 1183817 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the cl